• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Frankfurt	113,200	18.07.24 18:43:11	-1,800	-1,57%	0,000	0,000	115,600	115,000
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	91,500	18.07.24 15:53:36	+1,000	+1,10%	0,000	0,000	92,500	90,500